{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:47:33Z","timestamp":1791337653182,"version":"4.3.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002378","name":"Faculty of Veterinary Medicine, Cairo University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002378","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024002","name":"Faculty of Veterinary Medicine, Damanhour University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017160","name":"Beni-Suef University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.lfs.2024.122995","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T06:13:02Z","timestamp":1723875182000},"page":"122995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Enhanced eNOS\/nitric oxide production by nebivolol interferes with TGF-\u03b21\/Smad3 signaling and collagen I deposition in the kidney after prolonged tacrolimus administration"],"prefix":"10.1016","volume":"355","author":[{"given":"Amany A.","family":"Azouz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Tohamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fares E.M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba M.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lfs.2024.122995_bb0005","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1093\/labmed\/lmx056","article-title":"Tacrolimus: a review of laboratory detection methods and indications for use","volume":"48","author":"Kalt","year":"2017","journal-title":"Lab. Med."},{"issue":"3","key":"10.1016\/j.lfs.2024.122995_bb0010","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/TP.0000000000003350","article-title":"Thirty years of tacrolimus in clinical practice","volume":"105","author":"Ong","year":"2021","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.lfs.2024.122995_bb0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5125\/jkaoms.2023.49.6.311","article-title":"Review of two immunosuppressants: tacrolimus and cyclosporine","volume":"49","author":"Lee","year":"2023","journal-title":"J. Korean Assoc. Oral Maxillofac. Surg."},{"issue":"5","key":"10.1016\/j.lfs.2024.122995_bb0020","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.intimp.2009.01.029","article-title":"Low-dose of tacrolimus favors the induction of functional CD4+ CD25+ FoxP3+ regulatory T cells in solid-organ transplantation","volume":"9","author":"Wang","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2024.122995_bb0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00228-016-2140-z","article-title":"FOXP3 rs3761548 polymorphism is associated with tacrolimus-induced acute nephrotoxicity in renal transplant patients","volume":"73","author":"Wu","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2024.122995_bb0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.molimm.2016.08.017","article-title":"The tyrosine kinase inhibitor tyrphostin AG126 reduces activation of inflammatory cells and increases Foxp3+ regulatory T cells during pathogenesis of rheumatoid arthritis","volume":"78","author":"Ahmad","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.lfs.2024.122995_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2018.08.013","article-title":"Activation of renal profibrotic TGF\u03b2 controlled signaling cascades by calcineurin and mTOR inhibitors","volume":"52","author":"Eberhardt","year":"2018","journal-title":"Cell. Signal."},{"issue":"5","key":"10.1016\/j.lfs.2024.122995_bb0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/jcm5050050","article-title":"Tacrolimus modulates TGF-\u03b2 signaling to induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells","volume":"5","author":"Bennett","year":"2016","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.lfs.2024.122995_bb0045","doi-asserted-by":"crossref","first-page":"F433","DOI":"10.1152\/ajprenal.00226.2022","article-title":"Tacrolimus induces fibroblast-to-myofibroblast transition via a TGF-\u03b2-dependent mechanism to contribute to renal fibrosis","volume":"324","author":"Ume","year":"2023","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.lfs.2024.122995_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2015.00082","article-title":"TGF-\u03b2\/Smad signaling in renal fibrosis","volume":"6","author":"Meng","year":"2015","journal-title":"Front. Physiol."},{"issue":"7","key":"10.1016\/j.lfs.2024.122995_bb0055","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.7150\/ijbs.71595","article-title":"Smad3 signatures in renal inflammation and fibrosis","volume":"18","author":"Wu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2024.122995_bb0060","doi-asserted-by":"crossref","first-page":"2147083","DOI":"10.1080\/0886022X.2022.2147083","article-title":"Exploration of the mechanism of NORAD activation of TGF-\u03b21\/Smad3 through miR-136-5p and promotion of tacrolimus-induced renal fibrosis","volume":"45","author":"Liu","year":"2023","journal-title":"Ren. Fail."},{"issue":"2","key":"10.1016\/j.lfs.2024.122995_bb0065","doi-asserted-by":"crossref","first-page":"167","DOI":"10.33549\/physiolres.933332","article-title":"Pathophysiological mechanisms of calcineurin inhibitor-induced nephrotoxicity and arterial hypertension","volume":"66","author":"Ho\u0161kov\u00e1","year":"2017","journal-title":"Physiol. Res."},{"issue":"7","key":"10.1016\/j.lfs.2024.122995_bb0070","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.transproceed.2004.08.109","article-title":"Effect of tacrolimus and cyclosporine on renal microcirculation and nitric oxide production","volume":"36","author":"Watarai","year":"2004","journal-title":"Transplant. Proc."},{"issue":"12","key":"10.1016\/j.lfs.2024.122995_bb0075","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.4049\/jimmunol.1100485","article-title":"Nitric oxide modulates TGF-\u03b2\u2013directive signals to suppress Foxp3+ regulatory T cell differentiation and potentiate Th1 development","volume":"186","author":"Lee","year":"2011","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.lfs.2024.122995_bb0080","first-page":"1921","article-title":"Role of nitric oxide in antagonistic effects of transforming growth factor-beta and interleukin-1 beta on the beating rate of cultured cardiac myocytes","volume":"6","author":"Roberts","year":"1992","journal-title":"Mol. Endocrinol."},{"issue":"11","key":"10.1016\/j.lfs.2024.122995_bb0085","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/01.RES.0000191538.76771.66","article-title":"Nitric oxide regulates transforming growth factor-\u03b2 signaling in endothelial cells","volume":"97","author":"Saura","year":"2005","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.lfs.2024.122995_bb0090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/1753944709104496","article-title":"Nitric oxide mechanisms of nebivolol","volume":"3","author":"Maffei","year":"2009","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"10.1016\/j.lfs.2024.122995_bb0095","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s40265-015-0435-5","article-title":"A review of nebivolol pharmacology and clinical evidence","volume":"75","author":"Fongemie","year":"2015","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.lfs.2024.122995_bb0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1755-5922.2008.00054.x","article-title":"Nebivolol: a highly selective \u03b21-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide","volume":"26","author":"Gupta","year":"2008","journal-title":"Cardiovasc. Ther."},{"issue":"4","key":"10.1016\/j.lfs.2024.122995_bb0105","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/ATVBAHA.114.303290","article-title":"Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis","volume":"34","author":"Momi","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.lfs.2024.122995_bb0110","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.pharep.2015.03.008","article-title":"Anti-thrombotic effects of nebivolol and carvedilol: involvement of \u03b22 receptors and COX-2\/PGI2 pathways","volume":"67","author":"Kozlovski","year":"2015","journal-title":"Pharmacol. Rep."},{"issue":"6","key":"10.1016\/j.lfs.2024.122995_bb0115","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1161\/HYPERTENSIONAHA.115.06979","article-title":"Chronic nebivolol treatment suppresses endothelin-1\u2013mediated vasoconstrictor tone in adults with elevated blood pressure","volume":"67","author":"Diehl","year":"2016","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.lfs.2024.122995_bb0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/bcpt.13248","article-title":"Nebivolol in the treatment of arterial hypertension","volume":"125","author":"Olawi","year":"2019","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.lfs.2024.122995_bb0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.freeradbiomed.2013.06.033","article-title":"Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-\u03b2 and MMPs, and decreases vascular remodeling in renovascular hypertension","volume":"65","author":"Ceron","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"10","key":"10.1016\/j.lfs.2024.122995_bb0130","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/labinvest.2015.93","article-title":"Inhibition of dipeptidyl peptidase IV protects tacrolimus-induced kidney injury","volume":"95","author":"Lim","year":"2015","journal-title":"Lab. Investig."},{"issue":"1","key":"10.1016\/j.lfs.2024.122995_bb0135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12882-019-1399-6","article-title":"Cilastatin protects against tacrolimus-induced nephrotoxicity via anti-oxidative and anti-apoptotic properties","volume":"20","author":"Luo","year":"2019","journal-title":"BMC Nephrol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122995_bb0140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41401-020-0449-8","article-title":"L-carnitine protects against tacrolimus-induced renal injury by attenuating programmed cell death via PI3K\/AKT\/PTEN signaling","volume":"42","author":"Zheng","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"11","key":"10.1016\/j.lfs.2024.122995_bb0145","first-page":"718","article-title":"Protective effect of nebivolol on gentamicin-induced nephrotoxicity in rats","volume":"119","author":"Dursun","year":"2018","journal-title":"Bratisl. Lek. Listy"},{"key":"10.1016\/j.lfs.2024.122995_bb0150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.etap.2019.03.018","article-title":"Modulation of eNOS\/iNOS by nebivolol protects against cyclosporine A-mediated nephrotoxicity through targeting inflammatory and apoptotic pathways","volume":"69","author":"El-Sheikh","year":"2019","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122995_bb0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1081\/JDI-100001279","article-title":"Effects of nitric oxide synthesis inhibition on FK506-induced nephrotoxicity in rats","volume":"23","author":"Wang","year":"2001","journal-title":"Ren. Fail."},{"issue":"6","key":"10.1016\/j.lfs.2024.122995_bb0160","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2174\/1389200219666180129151948","article-title":"Pharmacokinetics, pharmacodynamics and pharmacogenetics of tacrolimus in kidney transplantation","volume":"19","author":"Yu","year":"2018","journal-title":"Curr. Drug Metab."},{"issue":"2","key":"10.1016\/j.lfs.2024.122995_bb0165","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jsps.2021.12.013","article-title":"Interference with megalin expression\/endocytic function by montelukast mitigates gentamicin nephrotoxicity: downregulation of ClC-5 expression","volume":"30","author":"Azouz","year":"2022","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.lfs.2024.122995_bb0170","series-title":"Theory and Practice of Histological Techniques","author":"Bancroft","year":"2008"},{"key":"10.1016\/j.lfs.2024.122995_bb0175","series-title":"The toxicologist\u2019s Pocket Handbook","article-title":"Risk assessment","author":"Derelanko","year":"2018"},{"issue":"3","key":"10.1016\/j.lfs.2024.122995_bb0180","doi-asserted-by":"crossref","first-page":"321","DOI":"10.18678\/dtfd.1198021","article-title":"Ellagic acid inhibits TGF\u03b21\/Smad-induced renal fibrosis in diabetic kidney injury","volume":"24","author":"Sariba\u015e","year":"2022","journal-title":"Duzce Med. J."},{"key":"10.1016\/j.lfs.2024.122995_bb0185","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biopha.2018.12.060","article-title":"Inhibition of spleen tyrosine kinase attenuates psoriasis-like inflammation in mice through blockade of dendritic cell-Th17 inflammation axis","volume":"111","author":"Alzahrani","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2024.122995_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2019.12.003","article-title":"Inhibition of tyrosine kinase signaling by tyrphostin AG126 downregulates the IL-21\/IL-21R and JAK\/STAT pathway in the BTBR mouse model of autism","volume":"77","author":"Ahmad","year":"2020","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.lfs.2024.122995_bb0195","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.biocel.2016.03.001","article-title":"Inhibition of spleen tyrosine kinase (syk) suppresses renal fibrosis through anti-inflammatory effects and down regulation of the MAPK-p38 pathway","volume":"74","author":"Chen","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"8","key":"10.1016\/j.lfs.2024.122995_bb0200","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1097\/TP.0000000000001826","article-title":"Inhibition of spleen tyrosine kinase reduces renal allograft injury in a rat model of acute antibody-mediated rejection in sensitized recipients","volume":"101","author":"Chandran","year":"2017","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.lfs.2024.122995_bb0205","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/jch.12745","article-title":"Nebivolol effects on nitric oxide levels, blood pressure, and renal function in kidney transplant patients","volume":"18","author":"Santos","year":"2016","journal-title":"J. Clin. Hypertens."},{"issue":"12","key":"10.1016\/j.lfs.2024.122995_bb0210","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/00007890-199712270-00034","article-title":"Mechanism of fibrosis in experimental tacrolimus nephrotoxicity","volume":"64","author":"Shihab","year":"1997","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.lfs.2024.122995_bb0215","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/CS20120252","article-title":"Role of the TGF-\u03b2\/BMP-7\/Smad pathways in renal diseases","volume":"124","author":"Meng","year":"2013","journal-title":"Clin. Sci."},{"issue":"11","key":"10.1016\/j.lfs.2024.122995_bb0220","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/1440-1681.13001","article-title":"Nebivolol ameliorated kidney damage in Zucker diabetic fatty rats by regulation of oxidative stress\/NO pathway: comparison with captopril","volume":"45","author":"Wang","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"12","key":"10.1016\/j.lfs.2024.122995_bb0225","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1097\/HJH.0b013e3282efeecb","article-title":"Long-term nebivolol administration reduces renal fibrosis and prevents endothelial dysfunction in rats with hypertension induced by renal mass reduction","volume":"25","author":"Pires","year":"2007","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.lfs.2024.122995_bb0230","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000278757","article-title":"Nebivolol attenuates maladaptive proximal tubule remodeling in transgenic rats","volume":"31","author":"Hayden","year":"2010","journal-title":"Am. J. Nephrol."},{"issue":"5","key":"10.1016\/j.lfs.2024.122995_bb0235","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3390\/cells11050883","article-title":"Nebivolol increases nitric oxide synthase via \u03b23 adrenergic receptor in endothelial cells following exposure to plasma from preeclamptic patients","volume":"11","author":"Bueno-Pereira","year":"2022","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.lfs.2024.122995_bb0240","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/CIRCULATIONAHA.104.532960","article-title":"Endothelial \u03b23-adrenoreceptors mediate nitric oxide\u2013dependent vasorelaxation of coronary microvessels in response to the third-generation \u03b2-blocker nebivolol","volume":"112","author":"Dessy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2024.122995_bb0245","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.toxlet.2021.01.020","article-title":"Establishment of an experimental rat model of tacrolimus-induced kidney injury accompanied by interstitial fibrosis","volume":"341","author":"Fu","year":"2021","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.lfs.2024.122995_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120154","article-title":"Impact of the ACE2 activator xanthenone on tacrolimus nephrotoxicity: modulation of uric acid\/ERK\/p38 MAPK and Nrf2\/SOD3\/GCLC signaling pathways","volume":"288","author":"Azouz","year":"2022","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.lfs.2024.122995_bb0255","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3390\/diagnostics13111843","article-title":"Evaluation of NAG, NGAL, and KIM-1 as prognostic markers of the initial evolution of kidney transplantation","volume":"13","author":"Tabernero","year":"2023","journal-title":"Diagnostics"},{"issue":"10","key":"10.1016\/j.lfs.2024.122995_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110527","article-title":"Urinary neutrophil gelatinase-associated lipocalin: a useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients","volume":"9","author":"Tsuchimoto","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.lfs.2024.122995_bb0265","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41401-018-0070-2","article-title":"Biomarkers for individualized dosage adjustments in immunosuppressive therapy using calcineurin inhibitors after organ transplantation","volume":"40","author":"Fu","year":"2019","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052400585X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052400585X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T17:43:40Z","timestamp":1725903820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052400585X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":53,"alternative-id":["S002432052400585X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122995","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced eNOS\/nitric oxide production by nebivolol interferes with TGF-\u03b21\/Smad3 signaling and collagen I deposition in the kidney after prolonged tacrolimus administration","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122995"}}